LinkedIn Profile

Access NeuroQuest historical Linkedin company profile data on number of followers, employee headcount and more

Records

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:neuroquest 3070353 May 30th, 2019 12:00AM NeuroQuest 113 13.00 Open Biotechnology May 30th, 2019 01:46PM May 30th, 2019 01:46PM NeuroQuest is developing biomarkers for the early and accurate diagnosis of Alzheimer’s and ALS Diseases. NeuroQuest's diagnostics are blood-based immune biomarkers in AD and ALS patients. Blood samples are processed by standard laboratory approaches to measure novel and patent pending aspects of the peripheral immune system that reflect the disease pathology and can be used for diagnosis, prognosis, and monitoring disease progression. These patented biomarkers may lead to a better understanding of the mechanism of neurodegenerative disease, leading to improved therapeutics. NeuroQuest is a portfolio company of the Trendlines Group, with additional investments from the Maryland-Israel Trendlines Fund, and the InterTech Group. Open Alzheimer's Disease, ALS Disease, Biomarkers, Diagnostics Open 17 Techelet (Sky) St. M.P. Misgav IL 20174 Health Care Health Care Equipment & Services
private:neuroquest 3070353 Dec 16th, 2017 12:00AM NeuroQuest 101 16.00 Open Biotechnology Dec 16th, 2017 02:21PM Dec 16th, 2017 02:21PM NeuroQuest is developing biomarkers for the early and accurate diagnosis of Alzheimer’s and ALS Diseases. NeuroQuest's diagnostics are blood-based immune biomarkers in AD and ALS patients. Blood samples are processed by standard laboratory approaches to measure novel and patent pending aspects of the peripheral immune system that reflect the disease pathology and can be used for diagnosis, prognosis, and monitoring disease progression. These patented biomarkers may lead to a better understanding of the mechanism of neurodegenerative disease, leading to improved therapeutics. NeuroQuest is a portfolio company of the Trendlines Group, with additional investments from the Maryland-Israel Trendlines Fund, and the InterTech Group. Health Care Health Care Equipment & Services
private:neuroquest 3070353 Dec 17th, 2017 12:00AM NeuroQuest 101 16.00 Open Biotechnology Dec 17th, 2017 08:12AM Dec 17th, 2017 08:12AM NeuroQuest is developing biomarkers for the early and accurate diagnosis of Alzheimer’s and ALS Diseases. NeuroQuest's diagnostics are blood-based immune biomarkers in AD and ALS patients. Blood samples are processed by standard laboratory approaches to measure novel and patent pending aspects of the peripheral immune system that reflect the disease pathology and can be used for diagnosis, prognosis, and monitoring disease progression. These patented biomarkers may lead to a better understanding of the mechanism of neurodegenerative disease, leading to improved therapeutics. NeuroQuest is a portfolio company of the Trendlines Group, with additional investments from the Maryland-Israel Trendlines Fund, and the InterTech Group. Health Care Health Care Equipment & Services
private:neuroquest 3070353 Dec 18th, 2017 12:00AM NeuroQuest 101 16.00 Open Biotechnology Dec 18th, 2017 10:19AM Dec 18th, 2017 10:19AM NeuroQuest is developing biomarkers for the early and accurate diagnosis of Alzheimer’s and ALS Diseases. NeuroQuest's diagnostics are blood-based immune biomarkers in AD and ALS patients. Blood samples are processed by standard laboratory approaches to measure novel and patent pending aspects of the peripheral immune system that reflect the disease pathology and can be used for diagnosis, prognosis, and monitoring disease progression. These patented biomarkers may lead to a better understanding of the mechanism of neurodegenerative disease, leading to improved therapeutics. NeuroQuest is a portfolio company of the Trendlines Group, with additional investments from the Maryland-Israel Trendlines Fund, and the InterTech Group. Health Care Health Care Equipment & Services
private:neuroquest 3070353 Dec 19th, 2017 12:00AM NeuroQuest 101 16.00 Open Biotechnology Dec 19th, 2017 05:03AM Dec 19th, 2017 05:03AM NeuroQuest is developing biomarkers for the early and accurate diagnosis of Alzheimer’s and ALS Diseases. NeuroQuest's diagnostics are blood-based immune biomarkers in AD and ALS patients. Blood samples are processed by standard laboratory approaches to measure novel and patent pending aspects of the peripheral immune system that reflect the disease pathology and can be used for diagnosis, prognosis, and monitoring disease progression. These patented biomarkers may lead to a better understanding of the mechanism of neurodegenerative disease, leading to improved therapeutics. NeuroQuest is a portfolio company of the Trendlines Group, with additional investments from the Maryland-Israel Trendlines Fund, and the InterTech Group. Health Care Health Care Equipment & Services
private:neuroquest 3070353 Dec 21st, 2017 12:00AM NeuroQuest 101 16.00 Open Biotechnology Dec 21st, 2017 12:42PM Dec 21st, 2017 12:42PM NeuroQuest is developing biomarkers for the early and accurate diagnosis of Alzheimer’s and ALS Diseases. NeuroQuest's diagnostics are blood-based immune biomarkers in AD and ALS patients. Blood samples are processed by standard laboratory approaches to measure novel and patent pending aspects of the peripheral immune system that reflect the disease pathology and can be used for diagnosis, prognosis, and monitoring disease progression. These patented biomarkers may lead to a better understanding of the mechanism of neurodegenerative disease, leading to improved therapeutics. NeuroQuest is a portfolio company of the Trendlines Group, with additional investments from the Maryland-Israel Trendlines Fund, and the InterTech Group. Health Care Health Care Equipment & Services
private:neuroquest 3070353 Dec 22nd, 2017 12:00AM NeuroQuest 101 16.00 Open Biotechnology Dec 22nd, 2017 05:53AM Dec 22nd, 2017 05:53AM NeuroQuest is developing biomarkers for the early and accurate diagnosis of Alzheimer’s and ALS Diseases. NeuroQuest's diagnostics are blood-based immune biomarkers in AD and ALS patients. Blood samples are processed by standard laboratory approaches to measure novel and patent pending aspects of the peripheral immune system that reflect the disease pathology and can be used for diagnosis, prognosis, and monitoring disease progression. These patented biomarkers may lead to a better understanding of the mechanism of neurodegenerative disease, leading to improved therapeutics. NeuroQuest is a portfolio company of the Trendlines Group, with additional investments from the Maryland-Israel Trendlines Fund, and the InterTech Group. Health Care Health Care Equipment & Services
private:neuroquest 3070353 Dec 23rd, 2017 12:00AM NeuroQuest 101 16.00 Open Biotechnology Dec 23rd, 2017 09:37AM Dec 23rd, 2017 09:37AM NeuroQuest is developing biomarkers for the early and accurate diagnosis of Alzheimer’s and ALS Diseases. NeuroQuest's diagnostics are blood-based immune biomarkers in AD and ALS patients. Blood samples are processed by standard laboratory approaches to measure novel and patent pending aspects of the peripheral immune system that reflect the disease pathology and can be used for diagnosis, prognosis, and monitoring disease progression. These patented biomarkers may lead to a better understanding of the mechanism of neurodegenerative disease, leading to improved therapeutics. NeuroQuest is a portfolio company of the Trendlines Group, with additional investments from the Maryland-Israel Trendlines Fund, and the InterTech Group. Health Care Health Care Equipment & Services
private:neuroquest 3070353 Dec 24th, 2017 12:00AM NeuroQuest 101 16.00 Open Biotechnology Dec 24th, 2017 01:22PM Dec 24th, 2017 01:22PM NeuroQuest is developing biomarkers for the early and accurate diagnosis of Alzheimer’s and ALS Diseases. NeuroQuest's diagnostics are blood-based immune biomarkers in AD and ALS patients. Blood samples are processed by standard laboratory approaches to measure novel and patent pending aspects of the peripheral immune system that reflect the disease pathology and can be used for diagnosis, prognosis, and monitoring disease progression. These patented biomarkers may lead to a better understanding of the mechanism of neurodegenerative disease, leading to improved therapeutics. NeuroQuest is a portfolio company of the Trendlines Group, with additional investments from the Maryland-Israel Trendlines Fund, and the InterTech Group. Health Care Health Care Equipment & Services
private:neuroquest 3070353 Dec 25th, 2017 12:00AM NeuroQuest 101 16.00 Open Biotechnology Dec 25th, 2017 10:21AM Dec 25th, 2017 10:21AM NeuroQuest is developing biomarkers for the early and accurate diagnosis of Alzheimer’s and ALS Diseases. NeuroQuest's diagnostics are blood-based immune biomarkers in AD and ALS patients. Blood samples are processed by standard laboratory approaches to measure novel and patent pending aspects of the peripheral immune system that reflect the disease pathology and can be used for diagnosis, prognosis, and monitoring disease progression. These patented biomarkers may lead to a better understanding of the mechanism of neurodegenerative disease, leading to improved therapeutics. NeuroQuest is a portfolio company of the Trendlines Group, with additional investments from the Maryland-Israel Trendlines Fund, and the InterTech Group. Health Care Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.